CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...